Effect of a dynamic wrist-hand orthosis combined with modified constraint-induced movement therapy on upper limb and hand function in acute and sub-acute stroke patients: a randomized controlled trial.
{"title":"Effect of a dynamic wrist-hand orthosis combined with modified constraint-induced movement therapy on upper limb and hand function in acute and sub-acute stroke patients: a randomized controlled trial.","authors":"Songhua Huang, Tianhao Gao, Junqi Ling, Jing Tian, Chan Chen, Rongrong Lu, Yulong Bai","doi":"10.1080/10749357.2026.2648215","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Constraint-Induced Movement Therapy (CIMT) is a \"rehabilitation strategy\" supported by numerous basic studies. However, its clinical implementation is often limited by the poor ability of the affected limb.</p><p><strong>Objectives: </strong>To combine mCIMT plus a SaeboGlove for persons who would not normally qualify for mCIMT training.</p><p><strong>Methods: </strong>Part A: mCIMT+Saebo group (<i>n</i> = 18) and mCIMT group (<i>n</i> = 19). Part B: mCIMT+Saebo group (<i>n</i> = 10) and control group (<i>n</i> = 9). Both parts were assessor-blinded, two-arm, parallel-group randomized controlled trials. In addition to conventional rehabilitation therapy, all groups, except the control group, underwent mCIMT. The mCIMT group wore a mitt for approximately 4 hours per day, 5 days a week, for 3 consecutive weeks. The mCIMT+Saebo group wore both the SaeboGlove and a mitt for the same duration.</p><p><strong>Results: </strong>Part A: Wolf Motor Function Test (WMFT) showed that mCIMT+Saebo group scored 7.23 points higher (95% CI 1.93 to 12.53) than mCIMT group (P < 0.05). Hand grip strength (item 14 of WMFT) scored 3.29 points higher (95% CI 1.35 to 5.24) than in the mCIMT group (P < 0.01). Part B: The WMFT showed that mCIMT+Saebo group scored 5.45 points higher (95% CI 1.92 to 8.98) than the control group (P < 0.01). Hand grip strength was 2.66 points higher (95% CI 1.33 to 3.99) (P < 0.001), and ARAT was 10.75 points higher (95% CI 0.93 to 20.57) than in the control group (P < 0.05).</p><p><strong>Conclusions: </strong>The SaeboGlove may enhance the therapeutic advantages of mCIMT and expand the inclusion criteria for CIMT.</p>","PeriodicalId":23164,"journal":{"name":"Topics in Stroke Rehabilitation","volume":" ","pages":"789-799"},"PeriodicalIF":2.3000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Topics in Stroke Rehabilitation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10749357.2026.2648215","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"REHABILITATION","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Constraint-Induced Movement Therapy (CIMT) is a "rehabilitation strategy" supported by numerous basic studies. However, its clinical implementation is often limited by the poor ability of the affected limb.
Objectives: To combine mCIMT plus a SaeboGlove for persons who would not normally qualify for mCIMT training.
Methods: Part A: mCIMT+Saebo group (n = 18) and mCIMT group (n = 19). Part B: mCIMT+Saebo group (n = 10) and control group (n = 9). Both parts were assessor-blinded, two-arm, parallel-group randomized controlled trials. In addition to conventional rehabilitation therapy, all groups, except the control group, underwent mCIMT. The mCIMT group wore a mitt for approximately 4 hours per day, 5 days a week, for 3 consecutive weeks. The mCIMT+Saebo group wore both the SaeboGlove and a mitt for the same duration.
Results: Part A: Wolf Motor Function Test (WMFT) showed that mCIMT+Saebo group scored 7.23 points higher (95% CI 1.93 to 12.53) than mCIMT group (P < 0.05). Hand grip strength (item 14 of WMFT) scored 3.29 points higher (95% CI 1.35 to 5.24) than in the mCIMT group (P < 0.01). Part B: The WMFT showed that mCIMT+Saebo group scored 5.45 points higher (95% CI 1.92 to 8.98) than the control group (P < 0.01). Hand grip strength was 2.66 points higher (95% CI 1.33 to 3.99) (P < 0.001), and ARAT was 10.75 points higher (95% CI 0.93 to 20.57) than in the control group (P < 0.05).
Conclusions: The SaeboGlove may enhance the therapeutic advantages of mCIMT and expand the inclusion criteria for CIMT.
期刊介绍:
Topics in Stroke Rehabilitation is the leading journal devoted to the study and dissemination of interdisciplinary, evidence-based, clinical information related to stroke rehabilitation. The journal’s scope covers physical medicine and rehabilitation, neurology, neurorehabilitation, neural engineering and therapeutics, neuropsychology and cognition, optimization of the rehabilitation system, robotics and biomechanics, pain management, nursing, physical therapy, cardiopulmonary fitness, mobility, occupational therapy, speech pathology and communication. There is a particular focus on stroke recovery, improving rehabilitation outcomes, quality of life, activities of daily living, motor control, family and care givers, and community issues.
The journal reviews and reports clinical practices, clinical trials, state-of-the-art concepts, and new developments in stroke research and patient care. Both primary research papers, reviews of existing literature, and invited editorials, are included. Sharply-focused, single-issue topics, and the latest in clinical research, provide in-depth knowledge.